{"title":"第一人称,Toni Lemmetyinen","authors":"","doi":"10.1242/dmm.050195","DOIUrl":null,"url":null,"abstract":"\n First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Toni Lemmetyinen is first author on ‘ Fibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growth’, published in DMM. Toni is a PhD student in the lab of Saara Ollila at the University of Helsinki, investigating how stromal fibroblasts regulate the intestinal epithelium.","PeriodicalId":141347,"journal":{"name":"Disease Models & Mechanisms","volume":"60 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"First person – Toni Lemmetyinen\",\"authors\":\"\",\"doi\":\"10.1242/dmm.050195\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\\n First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Toni Lemmetyinen is first author on ‘ Fibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growth’, published in DMM. Toni is a PhD student in the lab of Saara Ollila at the University of Helsinki, investigating how stromal fibroblasts regulate the intestinal epithelium.\",\"PeriodicalId\":141347,\"journal\":{\"name\":\"Disease Models & Mechanisms\",\"volume\":\"60 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Disease Models & Mechanisms\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1242/dmm.050195\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Disease Models & Mechanisms","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1242/dmm.050195","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
First Person is a series of interviews with the first authors of a selection of papers published in Disease Models & Mechanisms, helping researchers promote themselves alongside their papers. Toni Lemmetyinen is first author on ‘ Fibroblast-derived EGF ligand neuregulin 1 induces fetal-like reprogramming of the intestinal epithelium without supporting tumorigenic growth’, published in DMM. Toni is a PhD student in the lab of Saara Ollila at the University of Helsinki, investigating how stromal fibroblasts regulate the intestinal epithelium.